DVG

DVG
Name	DVG
Field	Virology

DVG

DVG refers to a class of viral entities observed across diverse taxa, characterized by genomic deletions, rearrangements, or truncations that render them replication-defective in isolation. These particles arise during replication of RNA and DNA viruses and interact with canonical viral genomes, host pathways, and immune systems, influencing outcomes in infections, outbreaks, and experimental systems. Studies of DVGs intersect with research on Influenza A virus, Ebola virus, SARS-CoV-2, Measles virus, and Hepatitis B virus among many other pathogens.

Definition and Terminology

In virological literature, DVG denotes defective viral genomes detected as subgenomic or rearranged sequences derived from parental genomes such as those of Vesicular stomatitis Indiana virus, Sindbis virus, or Respiratory syncytial virus. Terminology includes related labels like defective interfering (DI) particles historically used in studies of Poliovirus, Vesicular stomatitis virus, and Sendai virus. Descriptors differentiate deletion DVGs, copy-back DVGs, and snap-back DVGs observed in contexts including experiments with Adenovirus, Herpes simplex virus, and Coxsackievirus. Taxon-specific nomenclature appears in literature on Retroviridae, Flaviviridae, Paramyxoviridae, and Orthomyxoviridae.

History and Origins

Research into DVGs began with early 20th-century observations of interfering particles during serial passage studies in systems like Tobacco mosaic virus and Vaccinia virus. Classic experiments by workers studying Semliki Forest virus and Sindbis virus in the mid-1900s documented interferent phenomena, later formalized with work on Vesicular stomatitis virus and Influenza virus in the 1950s–1970s. Molecular era advances using techniques developed for Sanger sequencing and later next-generation sequencing revealed detailed architectures of DVGs in outbreaks involving Ebola virus, Lassa virus, and SARS-CoV-2. Contemporary surveillance programs at institutions such as Centers for Disease Control and Prevention and World Health Organization have integrated DVG detection into pathogen genomics workflows.

Types and Classification

Taxonomic grouping of DVGs is pragmatic and based on structural features, generation mechanisms, and functional effects. Major classes include deletion DVGs—documented in studies of Adeno-associated virus, Hepatitis C virus, and Influenza B virus—and copy-back DVGs—frequently described in Paramyxoviridae members like Respiratory syncytial virus and Measles virus. Reassortant-like defective segments occur in segmented viruses such as Influenza A virus and Bunyavirus relatives; template-switching forms appear in Retrovirus research on Human immunodeficiency virus. Classification also considers size distribution, terminal complementarity, and presence of packaging signals identified in systems including Adenovirus and Herpesviridae.

Biological and Medical Significance

DVGs modulate infection dynamics in hosts ranging from plants infected by Tobacco mosaic virus to humans facing SARS-CoV-2 or Ebola virus disease. They can attenuate parental virus replication via competition for replication machinery, as seen in Poliovirus and Vesicular stomatitis Indiana virus models, or potentiate immune activation through pattern recognition receptors characterized in studies involving Toll-like receptor 3, RIG-I, and MDA5 in contexts such as Influenza A virus and Respiratory syncytial virus infection. Clinical correlations link DVG abundance with disease severity in cohorts studied by academic centers like Johns Hopkins Hospital and University of Oxford, and they influence persistence phenomena in chronic infections including Hepatitis B virus and Hepatitis C virus.

Detection and Characterization Methods

Characterization of DVGs uses molecular and computational pipelines adapted from work on Sanger sequencing, Illumina, and Oxford Nanopore Technologies platforms. Laboratory methods include RT-PCR assays tailored to junction sequences identified in investigations of Sindbis virus and Influenza A virus, Northern blotting used historically in Tobacco mosaic virus work, and deep sequencing coupled with algorithms developed in studies of SARS-CoV-2 and Ebola virus. Bioinformatic tools benchmarked against datasets from National Center for Biotechnology Information and repositories used by European Bioinformatics Institute enable detection of deletion breakpoints, copy-back structures, and chimeric reads. Electron microscopy and density gradient centrifugation remain useful for particle-level studies informed by classical work on Vaccinia virus and Adenovirus.

Impact on Viral Evolution and Epidemiology

DVGs shape intra-host diversity and can influence inter-host transmission dynamics documented in field investigations of Influenza A virus seasonal cycles, Nipah virus outbreaks, and Ebola virus epidemics. By altering selective pressures, DVGs contribute to mutation-load effects, complementation networks, and quasispecies behavior characterized in HIV-1 research. Epidemiological models incorporating interference phenomena have been applied to understand attenuation and outbreak suppression in settings studied by Centers for Disease Control and Prevention and public health agencies in United Kingdom and France. Phylogenetic analyses that integrate defective segments inform reconstructions of viral spread performed by groups at Wellcome Sanger Institute and Broad Institute.

Therapeutic and Research Applications

Exploiting DVG biology has inspired antiviral strategies, vaccine design, and experimental tools. Engineered defective particles have been evaluated as therapeutic agents in preclinical models of Influenza virus and Vesicular stomatitis virus, and as vaccine vectors building on platforms such as Adeno-associated virus and Modified vaccinia Ankara approaches. DVG-derived constructs serve as research reagents in reverse genetics systems used for SARS-CoV-2 and Measles virus studies, and as immunostimulatory adjuvants leveraging pathways mapped in research on RIG-I and Toll-like receptor 7. Clinical translation efforts involve collaborations among academic centers, biotechnology firms, and regulatory bodies including Food and Drug Administration and European Medicines Agency.

Category:Virology